Somatic mutations in miRNA genes in lung cancer – potential functional consequences of non-coding sequence variants
Authors:
Galka-Marciniak P, Urbanek-Trzeciak MO, Nawrocka PM, Dutkiewicz A, Giefing M, Lewandowska MA, Kozlowski P
Academic press:
Cancers (rok: 2019, tom: 11, strony: 793), Wydawca: MDPI
Consequences of genetic variants in miRNA genes
Authors:
Machowska M, Galka-Marciniak P, Kozlowski P
Academic press:
Computational and Structural Biotechnology Journal (rok: 2022, tom: 20, strony: 6443-6457), Wydawca: Elsevier
Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools
Authors:
Suszynska M, Ratajska M, Galka-Marciniak P, Ryszkowska A, Wydra D, Debniak J, Jasiak A, Wasag D, Cybulski C, Kozlowski P
Academic press:
Cancer Prevention Research (rok: 2022, tom: 15(3), strony: 151-160), Wydawca: American Association for Cancer Research
BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation
Authors:
Suszynska M, Kluzniak W, Wokolorczyk D, Jakubowska A, Huzarski T, Gronwald J, Debniak T, Szwiec M, Ratajska M, Klonowska K, Narod S, Bogdanova N, Dörk T, Lubinski J, Cybulski C, Kozlowski P
Academic press:
Cancers (rok: 2019, tom: 11, strony: 740), Wydawca: MDPI
Profile of basal cell carcinoma mutations and copy number alterations- focus on gene-associated noncoding variants
Authors:
Nawrocka PM, Galka-Marciniak P, Urbanek-Trzeciak MO, M-Thirusenthilarasan I, Szostak N, Philips A, Susok L, Sand M, Kozlowski P
Academic press:
Frontiers in Oncology (rok: 2021, tom: 11, strony: 752579), Wydawca: Frontiers Media SA
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels
Authors:
Lewandowski K, Kandula Z, Gniot M, Paczkowska E, Nawrocka PM, Wojtaszewska M, Janowski M, Mariak M, Handschuh L, Kozlowski P
Academic press:
Annals of Hematology (rok: 2022, tom: 101, strony: 2665-2667), Wydawca: Springer Link
CMC: Cancer miRNA Census - a list of cancer-related miRNA genes
Authors:
Suszynska M, Machowska M, FraszczykE, Michalczyk M, Philips A, Galka-Marciniak P, Kozlowski P
Academic press:
Nucleic Acids Research (rok: 2024, tom: 52, strony: 1628-1644), Wydawca: Oxford University Press
BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases
Authors:
Suszynska M, Ratajska M, Kozlowski P
Academic press:
Journal of Ovarian Research (rok: 2020, tom: 13, strony: 50), Wydawca: BMC
Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations
Authors:
Suszynska M, Kozlowski P
Academic press:
Genes (rok: 2020, tom: 11, strony: 798), Wydawca: MDPI
BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases
Authors:
Suszynska M, Ratajska M, Kozlowski P
Academic press:
Journal of Ovarian Research (rok: 2020, tom: 13, strony: 50), Wydawca: BMC
A pan-cancer atlas of somatic mutations in miRNA biogenesis genes
Authors:
Galka-Marciniak P, Urbanek-Trzeciak MO, Nawrocka PM, Kozlowski P
Academic press:
Nucleic Acids Research (rok: 2021, tom: 49, strony: 601-620), Wydawca: Oxford University Press
Consequences of genetic variants in miRNA genes
Authors:
Machowska M, Galka-Marciniak P, Kozlowski P
Academic press:
Computational and Structural Biotechnology Journal (rok: 2022, tom: 20, strony: 6443-6457), Wydawca: Elsevier
BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation
Authors:
Suszynska M, Kluzniak W, Wokolorczyk D, Jakubowska A, Huzarski T, Gronwald J, Debniak T, Szwiec M, Ratajska M, Klonowska K, Narod S, Bogdanova N, Dörk T, Lubinski J, Cybulski C, Kozlowski P
Academic press:
Cancers (rok: 2019, tom: 11, strony: 740), Wydawca: MDPI
Mutations in the miR-142 gene are not common in myeloproliferative neoplasms
Authors:
Galka-Marciniak P, Kandula Z, Tire A, Wegorek W, Gwozdz-Bak K, Handschuh L, Giefing M, Lewandowski K, Kozlowski P
Academic press:
Scientific Reports (rok: 2022, tom: 12(1), strony: 10924), Wydawca: Springer Nature
Pan-cancer analysis of somatic mutations in miRNA genes
Authors:
Urbanek-Trzeciak MO, Galka-Marciniak P, Nawrocka PM, Kowal E, Szwec S, Giefing M, Kozlowski P
Academic press:
EBioMedicine (rok: 2020, tom: 61, strony: 106031), Wydawca: Elsevier
qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites
Authors:
Dabrowska M, Czubak K, Juzwa W, Krzyzosiak WJ, Olejniczak M, Kozlowski P
Academic press:
Nucleic Acids Research (rok: 2018, tom: 46(17), strony: e101), Wydawca: Oxford Academic
Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes
Authors:
Suszynska M, Klonowska K, Jasinska AJ, Kozlowski P
Academic press:
Gynecologic Oncology (rok: 2019, tom: 153, strony: 452-462), Wydawca: Elsevier
miRMut: Annotation of mutation in miRNA genes from whole-exome or whole-genome sequencing
Authors:
Urbanek-Trzeciak MO, Kozlowski P, Galka-Marciniak P
Academic press:
STAR Protocols (rok: 2021, tom: 3 (1), strony: 101023), Wydawca: Elsevier